170 related articles for article (PubMed ID: 23556029)
1. Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.
Wilson S; Jones FM; Fofana HK; Doucouré A; Landouré A; Kimani G; Mwatha JK; Sacko M; Vennervald BJ; Dunne DW
PLoS Negl Trop Dis; 2013; 7(3):e2149. PubMed ID: 23556029
[TBL] [Abstract][Full Text] [Related]
2. A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils.
Wilson S; Jones FM; Fofana HK; Landouré A; Kimani G; Mwatha JK; Sacko M; Vennervald BJ; Dunne DW
Parasite Immunol; 2013 Jul; 35(7-8):224-8. PubMed ID: 23521712
[TBL] [Abstract][Full Text] [Related]
3. Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic community.
Asuming-Brempong EK; Ayi I; van der Puije W; Gyan BA; Larbi IA; Ashong Y; Frempong NA; Quartey JK; Otchere J; Jones FM; Wilson S; Dunne DW; Boakye DA
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010115. PubMed ID: 35263327
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.
Bourke CD; Nausch N; Rujeni N; Appleby LJ; Mitchell KM; Midzi N; Mduluza T; Mutapi F
J Infect Dis; 2013 Jul; 208(1):159-69. PubMed ID: 23045617
[TBL] [Abstract][Full Text] [Related]
5. Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment.
Bourke CD; Nausch N; Rujeni N; Appleby LJ; Trottein F; Midzi N; Mduluza T; Mutapi F
PLoS Negl Trop Dis; 2014 May; 8(5):e2846. PubMed ID: 24810615
[TBL] [Abstract][Full Text] [Related]
6. Human Schistosoma haematobium antifecundity immunity is dependent on transmission intensity and associated with immunoglobulin G1 to worm-derived antigens.
Wilson S; Jones FM; van Dam GJ; Corstjens PL; Riveau G; Fitzsimmons CM; Sacko M; Vennervald BJ; Dunne DW
J Infect Dis; 2014 Dec; 210(12):2009-16. PubMed ID: 25001462
[TBL] [Abstract][Full Text] [Related]
7. Human IgE response to the Schistosoma haematobium 22.6 kDa antigen.
Fitzsimmons CM; Stewart TJ; Hoffmann KF; Grogan JL; Yazdanbakhsh M; Dunne DW
Parasite Immunol; 2004; 26(8-9):371-6. PubMed ID: 15679635
[TBL] [Abstract][Full Text] [Related]
8. Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe.
Ndhlovu P; Cadman H; Vennervald BJ; Christensen NO; Chidimu M; Chandiwana SK
Parasite Immunol; 1996 Apr; 18(4):181-91. PubMed ID: 9223173
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.
Reimert CM; Fitzsimmons CM; Joseph S; Mwatha JK; Jones FM; Kimani G; Hoffmann KF; Booth M; Kabatereine NB; Dunne DW; Vennervald BJ
Clin Vaccine Immunol; 2006 May; 13(5):584-93. PubMed ID: 16682480
[TBL] [Abstract][Full Text] [Related]
10. Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel.
Satti MZ; Cahen P; Skov PS; Joseph S; Jones FM; Fitzsimmons C; Hoffmann KF; Reimert C; Kariuki HC; Kazibwe F; Mwatha JK; Kimani G; Vennervald BJ; Ouma JH; Kabatereine NB; Dunne DW
BMC Immunol; 2004 Apr; 5():6. PubMed ID: 15102330
[TBL] [Abstract][Full Text] [Related]
11. Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
Mitchell KM; Mutapi F; Mduluza T; Midzi N; Savill NJ; Woolhouse ME
PLoS Negl Trop Dis; 2014; 8(7):e3059. PubMed ID: 25079601
[TBL] [Abstract][Full Text] [Related]
12. Changes in the humoral immune responses after chemotherapy in single and co-infected individuals with Schisosoma haematobium and Plasmodium falciparum.
Zinyowera S; Muchaneta-Kubara CE; Mutapi F; Midzi N; Ndlovu PD; Mduluza T
Cent Afr J Med; 2006; 52(9-12):104-11. PubMed ID: 20353134
[TBL] [Abstract][Full Text] [Related]
13. Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children.
Naus CW; van Dam GJ; Kremsner PG; Krijger FW; Deelder AM
Clin Infect Dis; 1998 May; 26(5):1142-7. PubMed ID: 9597243
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4, immunoglobulin E and immunoglobulin A and resistance to re-infection with Schistosoma haematobium before and after chemotherapy.
Khalil HM; Abd el Baki MH; Abd el Mawla MM; Maklad KM; Sharaf SA; Saad AE
J Egypt Soc Parasitol; 1999 Aug; 29(2):395-408. PubMed ID: 10605492
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E.
Fitzsimmons CM; Joseph S; Jones FM; Reimert CM; Hoffmann KF; Kazibwe F; Kimani G; Mwatha JK; Ouma JH; Tukahebwa EM; Kariuki HC; Vennervald BJ; Kabatereine NB; Dunne DW
Infect Immun; 2004 Jul; 72(7):4023-30. PubMed ID: 15213147
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses in schistosomiasis haematobium in Somalia. Relation to age and infection intensity.
Hagi H; Huldt G; Loftenius A; Schröder H
Ann Trop Med Parasitol; 1990 Apr; 84(2):171-9. PubMed ID: 2116776
[TBL] [Abstract][Full Text] [Related]
17. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults.
Grogan JL; Kremsner PG; van Dam GJ; Metzger W; Mordmüller B; Deelder AM; Yazdanbakhsh M
J Infect Dis; 1996 May; 173(5):1242-7. PubMed ID: 8627078
[TBL] [Abstract][Full Text] [Related]
18. The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium.
Mutapi F; Mduluza T; Ndhlovu PD
Mem Inst Oswaldo Cruz; 2002; 97 Suppl 1():173-80. PubMed ID: 12426616
[TBL] [Abstract][Full Text] [Related]
19. Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel.
Joseph S; Jones FM; Walter K; Fulford AJ; Kimani G; Mwatha JK; Kamau T; Kariuki HC; Kazibwe F; Tukahebwa E; Kabatereine NB; Ouma JH; Vennervald BJ; Dunne DW
J Infect Dis; 2004 Aug; 190(4):835-42. PubMed ID: 15272413
[TBL] [Abstract][Full Text] [Related]
20. The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection.
Mduluza T; Ndhlovu PD; Madziwa TM; Midzi N; Zinyama R; Turner CM; Chandiwana SK; Nyazema N; Hagan P
Mem Inst Oswaldo Cruz; 2001; 96 Suppl():157-64. PubMed ID: 11586443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
